BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Diagnosis
7 results:

  • 1. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer.
    Heiduk M; Plesca I; Glück J; Müller L; Digomann D; Reiche C; von Renesse J; Decker R; Kahlert C; Sommer U; Aust DE; Schmitz M; Weitz J; Seifert L; Seifert AM
    JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36509285
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of il2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma.
    Ahmed A; Köhler S; Klotz R; Giese N; Lasitschka F; Hackert T; Springfeld C; Zörnig I; Jäger D; Halama N
    Oncoimmunology; 2021; 10(1):1962135. PubMed ID: 34408923
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Diagnostic Roles of Cytokines in Hepatobiliary cancers.
    Koca YS; Bulbul M; Barut I
    Biomed Res Int; 2017; 2017():2979307. PubMed ID: 29410961
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Depression, cytokines, and pancreatic cancer.
    Breitbart W; Rosenfeld B; Tobias K; Pessin H; Ku GY; Yuan J; Wolchok J
    Psychooncology; 2014 Mar; 23(3):339-45. PubMed ID: 24136882
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. il-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).
    Berković MC; Jokić M; Marout J; Radosević S; Zjacić-Rotkvić V; Kapitanović S
    J Mol Med (Berl); 2010 Apr; 88(4):423-9. PubMed ID: 20049409
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Combined immunopharmaceutical therapy of patients with unresectable pancreatic carcinoma.
    Lygidakis NJ; Ziras FA; Kyparidou E; Parissis J; Papadopoulou P; Venetsanou B
    Hepatogastroenterology; 1995; 42(6):1039-52. PubMed ID: 8847017
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.